Evidence map›Paper›PMID 27485778›Full record

ArticleCancer medicine2016

PRDM5 promotes the proliferation and invasion of murine melanoma cells through up-regulating JNK expression.

Lei Wang, Qiong-Qiong Ding, Shan-Shan Gao, Hai-Jie Yang, Mian Wang, Yu Shi, Bin-Feng Cheng, Jia-Jia Bi, Zhi-Wei Feng

Open access · goldAbstract read
In one paragraph

Article in Cancer medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.5field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Zeaxanthin-Rich Extract from SuperfoodMolecules (Basel, Switzerland) · 2021
    Article
  3. Article
  4. Multifaceted Role of PRDM Proteins in Human Cancer.International journal of molecular sciences · 2020
    Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Lei WangCollege of Life Science and Technology, Xinxiang Medical University, Xinxiang, China.
Qiong-Qiong DingCollege of Life Science and Technology, Xinxiang Medical University, Xinxiang, China.
Shan-Shan GaoCollege of Life Science and Technology, Xinxiang Medical University, Xinxiang, China.
Hai-Jie YangCollege of Life Science and Technology, Xinxiang Medical University, Xinxiang, China.
Mian WangCollege of Life Science and Technology, Xinxiang Medical University, Xinxiang, China.
Yu ShiCollege of Life Science and Technology, Xinxiang Medical University, Xinxiang, China.
Bin-Feng ChengCollege of Life Science and Technology, Xinxiang Medical University, Xinxiang, China.
Jia-Jia BiCollege of Life Science and Technology, Xinxiang Medical University, Xinxiang, China.
Zhi-Wei FengCollege of Life Science and Technology, Xinxiang Medical University, Xinxiang, China. 131035@xxmu.edu.cn, xxyxy_fzw@163.com.
Xinxiang Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PRDM (PRDI-BF1 and RIZ domain-containing) proteins constitute a family of zinc finger proteins and play important roles in multiple cellular processes by acting as epigenetic modifiers. PRDM5 is a recently identified member of the PRDM family and may function as a tumor suppressor in several types of cancer. However, the role of PRDM5 in murine melanoma remains largely unknown. In our study, effect of PRDM5 on murine melanoma cells was determined and results showed that PRDM5 overexpression significantly promoted proliferation, migration, and invasion of murine melanoma B16F10 cells. Consistently, silencing of PRDM5 expression significantly inhibited proliferation, invasion, and migration of B16F10 cells. In vivo study also showed that PRDM5 silencing significantly inhibited the growth and metastasis of melanoma in mice. PRDM5 was then found to increase the expression and activation of JNK in B16F10 cells. JNK silencing significantly reduced PRDM5-mediated up-regulation of JNK expression and blocked the PRDM5-induced proliferation and invasion of B16F10 cells. To further verify the involvement of JNK signaling in PRDM5-induced progression of B16F10 cells, a specific JNK inhibitor was employed to inhibit the JNK signaling pathway, and results showed that PRDM5-induced proliferation and invasion of B16F10 cells were abolished. We conclude that PRDM5 promotes the proliferation and invasion of murine melanoma cells through up-regulating JNK expression and strategies targeting PRDM5 may be promising for the therapy of melanoma.

Indexed as

Gene Expression Regulation, NeoplasticAnimalsCell Line, TumorCell MovementCell ProliferationDisease Models, AnimalDisease ProgressionDNA-Binding ProteinsFemaleGene ExpressionGene SilencingJNK Mitogen-Activated Protein KinasesMAP Kinase Signaling SystemMelanomaMelanoma, ExperimentalMiceDNA-Binding ProteinsJNK Mitogen-Activated Protein KinasesPRDM5 protein, mouseTranscription FactorsJNKmelanomametastasisPRDM5proliferation

Identifiers

PMID27485778
PMCPMC5055150
OpenAlexW2505712137

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.